Basic info
Industry
biotechnology research
Sectors
Biotechnology
Gorlin Syndrome
Health Care
Drug Formulation
Dermatology
Therapeutics
Pachyonychia Congenita
Orphan Diseases
Life Science
Date founded
2015
Funding rounds raised
Total raised
$45M
from 14 investors over 14 rounds
P
Palvella Therapeutics raised $38M on January 5, 2023
Investors: Samsara BioCapital, Nolan Capital, Inc., Gore Range Capital, -, Agent Capital and BioAdvance
P
Palvella Therapeutics raised $45M on May 28, 2020
Investors: BioAdvance, Samsara BioCapital, Adams Street Partners, Agent Capital, Nolan Capital, Inc. and Pharmacopeia now Ligand Pharmaceuticals
P
Palvella Therapeutics raised $10M on December 18, 2018
Investors: Pharmacopeia now Ligand Pharmaceuticals
P
Palvella Therapeutics raised undisclosed on August 14, 2017
Investors: BioAdvance